These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 27641463)
21. High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trial. Stiff PJ; Bayer R; Tan S; Camarda M; Sosman J; Peace D; Kinch L; Rad N; Loutfi S Clin Cancer Res; 1995 Dec; 1(12):1495-502. PubMed ID: 9815949 [TBL] [Abstract][Full Text] [Related]
22. High-dose chemotherapy: is it standard management for any common solid tumor? MacNeil M; Eisenhauer EA Ann Oncol; 1999 Oct; 10(10):1145-61. PubMed ID: 10586330 [TBL] [Abstract][Full Text] [Related]
23. High-dose chemotherapy with stem cell reinfusion and growth factor support for solid tumors. de Vries EG; de Graaf H; Boonstra A; van der Graaf WT; Mulder NH Stem Cells; 1995 Nov; 13(6):597-606. PubMed ID: 8590861 [TBL] [Abstract][Full Text] [Related]
29. The role of high-dose therapy and autologous stem cell transplantation for pediatric bone and soft tissue sarcomas. Ek ET; Choong PF Expert Rev Anticancer Ther; 2006 Feb; 6(2):225-37. PubMed ID: 16445375 [TBL] [Abstract][Full Text] [Related]
30. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649 [TBL] [Abstract][Full Text] [Related]
32. High-dose chemotherapy with bone marrow support for solid tumors. Antman K; Eder JP; Frei E Important Adv Oncol; 1987; ():221-35. PubMed ID: 2841230 [No Abstract] [Full Text] [Related]
33. High-dose Thiotepa as Consolidation Therapy With Autologous Hematopoietic Stem Cell Transplantation for High-risk Ewing Family Tumors: Single-institution Experience. Jahnukainen K; Kallio P; Koivusalo A; Saarinen-Pihkala UM J Pediatr Hematol Oncol; 2015 Oct; 37(7):536-42. PubMed ID: 26207773 [TBL] [Abstract][Full Text] [Related]
34. Bone marrow autotransplantation for solid tumors--prospects. Frei E; Antman K; Teicher B; Eder P; Schnipper L J Clin Oncol; 1989 Apr; 7(4):515-26. PubMed ID: 2647915 [TBL] [Abstract][Full Text] [Related]
35. [High-dose chemotherapy with transplantation of autologous stem cells in advanced germ-cell poor-risk testicular tumors]. May M; Georgieva G; Gunia S; Peter N; Steinhauer HB; Hoschke B Urologiia; 2007; (2):58-63. PubMed ID: 17578200 [TBL] [Abstract][Full Text] [Related]
36. High-dose thiotepa and hematopoietic stem cell transplantation in pediatric malignant mesenchymal tumors: a phase II study. Lafay-Cousin L; Hartmann ; Plouvier P; Méchinaud F; Boutard P; Oberlin O Bone Marrow Transplant; 2000 Sep; 26(6):627-32. PubMed ID: 11035368 [TBL] [Abstract][Full Text] [Related]
37. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
38. A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma. Weaver CH; Greco FA; Hainsworth JD; Zhen B; Baldwin P; Wittlin F; Lewis M; West WH; Schwartzberg L; Buckner CD Bone Marrow Transplant; 1997 Nov; 20(10):847-53. PubMed ID: 9404925 [TBL] [Abstract][Full Text] [Related]
39. High-dose ifosfamide as second- or third-line chemotherapy in refractory bone and soft tissue sarcoma patients. Lee SH; Chang MH; Baek KK; Han B; Lim T; Lee J; Park JO Oncology; 2011; 80(3-4):257-61. PubMed ID: 21734417 [TBL] [Abstract][Full Text] [Related]